Frequently Asked Questions
The andersen-Tawil Syndrome market is growing at a CAGR of 7.20% in the forecast by 2028.
The major players operating in the Andersen-Tawil Syndrome market are Aurobindo Pharma, Zydus Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Novartis AG, Viatris Inc., Advanz Pharmaceutical
Lack of awareness of the disorders in developing countries and till now no approved treatment for the disorders may hamper the global Andersen-Tawil Syndrome market.
The Andersen-Tawil Syndrome market is segmented on the basis of type, related disorders, end users and distribution channel.
The increasing prevalence of Andersen-Tawil Syndrome also boosts up the market growth. Moreover, rising advancements in diagnosis & treatment and the rise in government prioritization of drugs for rare disorders also boost up the market growth
